Baylink Biosciences is focused on developing innovative antibody-drug conjugates (ADCs) for cancer treatment. Baylink has created a panel of linker-payloads that enhance the delivery of hydrophobic compounds with high drug-to-antibody ratios (DAR) and stability. Baylink is advancing several product candidates based on this platform to the clinic that represent first-in-class or best-in-class ADC therapeutics.



Biotechnology

Pharmaceutical

Therapeutics

Baylink Biosciences

Baylink Biosciences' headquarters in Palo Alto, United States

Description

People (1)

Darren B.

Jobs